kpcczКомплексные проблемы сердечно-сосудистых заболеванийComplex Issues of Cardiovascular Diseases2306-12782587-9537Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”10.17802/2306-1278-2024-13-4S-197-207kpccz-1515Research ArticleАНАЛИТИЧЕСКИЙ ОБЗОР. Сердечно-сосудистая хирургияREVIEWS. Cardiovascular surgeryЭНДОВАСКУЛЯРНОЕ ТРАНСКАТЕТЕРНОЕ ЗАМЕЩЕНИЕ КЛАПАНА ЛЕГОЧНОЙ АРТЕРИИ С ПОМОЩЬЮ БАЛЛОН-РАСШИРЯЕМЫХ УСТРОЙСТВ (ОБЗОР ЛИТЕРАТУРЫ)ENDOVASCULAR TRANSCATHETER PULMONARY VALVE REPLACEMENT USING BALLOON-EXPANDABLE DEVICES: A LITERATURE REVIEWhttps://orcid.org/0000-0002-1421-1795ПурсановМанолис ГеоргиевичPursanovManolis G.

доктор медицинских наук, профессор врач – рентгенэндоваскулярный хирург отделения экстренной кардиохирургии и интервенционной кардиологии государственного бюджетного учреждения здравоохранения города Москвы «Морозовская детская городская клиническая больница Департамента здравоохранения города Москвы», Москва, Российская Федерация

PhD, Professor, Endovascular Surgeon at the Department of Emergency Cardiac Surgery and Interventional Cardiology, Moscow State Budgetary Healthcare Institution “Morozovskaya Children's City Clinical Hospital of the Moscow Department of Health”, Moscow, Russian Federati

agotskina@yandex.ruГосударственное бюджетное учреждение здравоохранения города Москвы «Морозовская детская городская клиническая больница Департамента здравоохранения города Москвы»РоссияMoscow State Budgetary Healthcare Institution “Morozovskaya Children's City Clinical Hospital of the Moscow Department of Health”Russian Federation202428122024134S197207Copyright © Пурсанов М.Г., 20252025Пурсанов М.Г.Pursanov M.G.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nii-kpssz.com/jour/article/view/1515Основные положения

Основные положения

Разработка новых клапанных устройств (SAPIEN, Myval) с большой размерной линейкой значительно расширила возможности эндоваскулярного лечения дисфункций клапана легочной артерии. Стало возможным устранить легочную регургитацию не только при обструкции выводного тракта правого желудочка, но и после наложения трансаннулярных заплат при расширенных размерах легочного ствола и выводного отдела правого желудочка. На основе анализа литературных данных в работе рассмотрены конструктивные особенности клапанов, показания к процедуре, методики и тактики имплантации, а также клинические результаты.

 

 

Резюме

Резюме

В работе проанализированы эффективность и безопасность эндоваскулярного транскатетерного замещения клапана легочной артерии с использованием баллон-расширяемых устройств. Выполнен обзор релевантной литературы за последние несколько лет, изучены данные клинических исследований и случаев из практики, проанализированы основные технические аспекты процедуры замещения клапана легочной артерии. Определены эффективность процедуры, показания к применению и осложнения. Можно сделать вывод о перспективности эндоваскулярного транскатетерного замещения клапана легочной артерии с помощью баллон-расширяемых устройств как альтернативного метода лечения определенных пациентов с пороками сердца. Однако для оптимизации техники и улучшения результатов процедуры необходимы дальнейшие исследования.

Highlights

Highlights

The development of new valve devices (SAPIEN, Myval) with a large size range has significantly expanded the possibilities of endovascular treatment of pulmonary valve dysfunction. It became possible to treat pulmonary regurgitation in patients with obstructive right ventricular outflow tract and in patients with transannular patch repair of pulmonary trunk and right ventricular outflow tract enlargement. Based on the analysis of literature data, this work examines modern valve design features, indications, methods and techniques of their implantation, as well as clinical results.

 

 

Abstract

Abstract

The paper analyzes the effectiveness and safety of endovascular transcatheter pulmonary valve replacement using balloon-expandable devices. The authors conducted a review of the literature on this topic, studied the available clinical trial data and case reports, and analyzed the main technical aspects of the replacement procedure. The study results helped to assess the effectiveness of the procedure, indications and complications associated with its use. It can be concluded that endovascular transcatheter pulmonary valve replacement using balloon-expandable devices is a promising alternative treatment method for certain patients with heart defects. However, further research is needed to optimize the technique and improve the results of the procedure.

Клапан легочной артерииЭндоваскулярная имплантация клапана легочной артерииТранскатетерное замещение клапана легочной артерииВрожденные пороки сердцаЛегочная регургитация • MelodySapienMyvalPulmonary valveEndovascular pulmonary valve implantationTranscatheter pulmonary valve replacementCongenital heart defectsPulmonary regurgitationMelodySapienMyvalReferencesShimazaki Y., Blackstone E.H., Kirklin J.W. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg 1984; 32: 257-259 doi: 10.1055/s-2007-1023399.Shimazaki Y., Blackstone E.H., Kirklin J.W. The natural history of isolated congenital pulmonary valve incompetence: surgical implications. Thorac Cardiovasc Surg 1984; 32: 257-259 doi: 10.1055/s-2007-1023399.Подзолков В.П., Самсонов В.Б., Чиаурели М.Р., Кокшенёв И.В., Сабиров Б.Н., Данилов Т.Ю., Ковалёв Д.В., Саидов М.А. Врожденные пороки клапанов сердца: современные подходы к диагностике и хирургическому лечению. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2017;18(3): 271-277. doi: 10.24022/1810-0694-2017-18-3-271-277Podzolkov V.P., Samsonov V.B., Chiaureli M.R., Kokshenev I.V., Sabirov B.N., Danilov T.Yu., Kovalev D.V., Saidov M.A. Congenital heart valve diseases: modern approaches to diagnosis and surgical treatment. Byulleten’ Nauchnogo Tsentra Serdechno-Sosudistoy Khirurgii imeni A.N. Bakuleva RAMN (The Bulletin of Bakoulev Center. Cardiovascular Diseases, Russian journal). 2017; 18 (3): 271–277. doi: 10.24022/1810-0694-2017-18-3-271-277 (In Russian)Warnes C.A. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 2005; 46: 1-8. doi: 10.1016/j.jacc.2009.06.048.Warnes C.A. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 2005; 46: 1-8. doi: 10.1016/j.jacc.2009.06.048.Подзолков В.П., Юрлов И.А., Данилов Т.Ю., Гаджиев А.А., Хассан А., Ковалев Д.В., Пурсанов М.Г., Донцова В.И., Астраханцева Т.О., Черногривов И.Е. Протезирование клапана легочной артерии в отдаленные сроки после радикальной коррекции врожденных пороков сердца с обструкцией легочного кровотока. Грудная и сердечно-сосудистая хирургия. 2008;4: 4-11.Podzolkov V.P., Yurlov I.A., Danilov T.Yu., Gadzhiyev A.A., Hasan A., Kovalev D.V., Pursanov M.G., Dontsova V.I., Astrakhantseva T.O., Chernogriuov I.Ye. Pulmonary arterial valve replacement in the late periods after radical correction of congenital heart disease with pulmonary blood flow obstruction. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2008;4: 4-11. (In Russian)Powell A.J., Lock J.E, Keane J.F., Perry S.B. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediateterm results. Circulation 1995; 92: 3282-3288. doi: 10.1161/01.CIR.92.11.3282.Powell A.J., Lock J.E, Keane J.F., Perry S.B. Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediateterm results. Circulation 1995; 92: 3282-3288. doi: 10.1161/01.CIR.92.11.3282.Oosterhof T., Meijboom F.J., Vliegen H.W., Hazekamp M.G., Zwinderman A.H., Bouma B.J., van Dijk A.P., Mulder B.J. Long-term followup of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006; 27: 1478-1484. doi: 10.1093/eurheartj/ehl033.Oosterhof T., Meijboom F.J., Vliegen H.W., Hazekamp M.G., Zwinderman A.H., Bouma B.J., van Dijk A.P., Mulder B.J. Long-term followup of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006; 27: 1478-1484. doi: 10.1093/eurheartj/ehl033.Corno A.F. Valved Conduits Right Ventricle to Pulmonary Artery for Complex Congenital Heart Defects. In: Cagini L. edited. Current Concepts in General Thoracic Surgery. InTech, 2012. doi: 10.5772/51081. Available from: URL: http:///cdn.intechopen.com/pdfs-wm/41324.pdf. (accessed 23.06.2024)Corno A.F. Valved Conduits Right Ventricle to Pulmonary Artery for Complex Congenital Heart Defects. In: Cagini L. edited. Current Concepts in General Thoracic Surgery. InTech, 2012. doi: 10.5772/51081. Available from: URL: http:///cdn.intechopen.com/pdfs-wm/41324.pdf. (accessed 23.06.2024)Алекян Б. Г., Подзолков В.П., Пурсанов М.Г., Юрлов И.А., Сандодзе Т.С., Данилов Т.Ю., Ковалев Д.В., Донцова В.И., Шинкарева Т.В. Эндоваскулярная имплантация клапана легочной артерии у пациента с транспозицией магистральных сосудов после многоэтапной хирургической коррекции. Грудная и сердечно-сосудистая хирургия. 2010;3:58-62.Alekjan B. G., Podzolkov V.P., Pursanov M.G., Jurlov I.A., Sandodze T.S., Danilov T.Ju., Kovalev D.V., Doncova V.I., Shinkareva T.V. Jendovaskuljarnaja implantacija klapana legochnoj arterii u pacienta s transpoziciej magistral'nyh sosudov posle mnogojetapnoj hirurgicheskoj korrekcii. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2010;3:58-62. (In Russian)Пурсанов М.Г., Абрамян М.А., Курако М.М., Пардаев Д.Б., Дишеков М.Р., Шамрин Ю.Н., Бедин А.В., Ефремов С.О . Транскатетерное замещение клапанов сердца у детей, первый клинический опыт. Эндоваскулярная хирургия. 2020; 7 (2): 149–60. doi: 10.24183/2409-4080-2020-7-2-149-160Pursanov M.G., Abramyan M.A., Kurako M.M., Pardaev D.B., Dishekov M.R., Shamrin Yu.N., Bedin A.V., Efremov S.O. Transcatheter replacement of heart valves in children: the first clinical experience. Russian Journal of Endovascular Surgery. 2020; 7 (2): 149–60. doi: 10.24183/2409-4080-2020-7-2-149-160 (In Russian)Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., Acar P., Le Bidois J., Sidi D., Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403-1405Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., Acar P., Le Bidois J., Sidi D., Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403-1405Martin M.H., Meadows J., McElhinney D.B., Goldstein B.H., Bergersen L., Qureshi A.M., Shahanavaz S., Aboulhosn J., Berman D., Peng L., Gillespie M., Armstrong A., Weng C., Minich L.L., Gray R.G. Safety and Feasibility of Melody Transcatheter Pulmonary Valve Replacement in the Native Right Ventricular Outflow Tract: A Multicenter Pediatric Heart Network Scholar Study. JACC Cardiovasc Interv. 2018;11(16):1642-1650. doi: 10.1016/j.jcin.2018.05.051.Martin M.H., Meadows J., McElhinney D.B., Goldstein B.H., Bergersen L., Qureshi A.M., Shahanavaz S., Aboulhosn J., Berman D., Peng L., Gillespie M., Armstrong A., Weng C., Minich L.L., Gray R.G. Safety and Feasibility of Melody Transcatheter Pulmonary Valve Replacement in the Native Right Ventricular Outflow Tract: A Multicenter Pediatric Heart Network Scholar Study. JACC Cardiovasc Interv. 2018;11(16):1642-1650. doi: 10.1016/j.jcin.2018.05.051.Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., Uebing A., Dähnert I., Röhle R., Schneider H., Witsenburg M., Benson L., Gitter R., Bökenkamp R., Mahadevan V., Berger F. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. doi: 10.1093/eurheartj/ehz201.Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., Uebing A., Dähnert I., Röhle R., Schneider H., Witsenburg M., Benson L., Gitter R., Bökenkamp R., Mahadevan V., Berger F. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. doi: 10.1093/eurheartj/ehz201.Cheatham S.L., Holzer R.J., Chisolm J.L., Cheatham J.P. The Medtronic Melody transcatheter pulmonary valve implanted at 24-mm diameter – it works. Catheter Cardiovasc Interv. 2013;82(5):816–823. doi:10.1002/ccd.24821Cheatham S.L., Holzer R.J., Chisolm J.L., Cheatham J.P. The Medtronic Melody transcatheter pulmonary valve implanted at 24-mm diameter – it works. Catheter Cardiovasc Interv. 2013;82(5):816–823. doi:10.1002/ccd.24821Malone L., Fonseca B., Fagan T., Gralla J., Wilson N., Vargas D., DiMaria M., Truong U., Browne L.P. Preprocedural Risk Assessment Prior to PPVI with CMR and Cardiac CT. Pediatr Cardiol. 2017;38(4):746-753. doi: 10.1007/s00246-017-1574-0.Malone L., Fonseca B., Fagan T., Gralla J., Wilson N., Vargas D., DiMaria M., Truong U., Browne L.P. Preprocedural Risk Assessment Prior to PPVI with CMR and Cardiac CT. Pediatr Cardiol. 2017;38(4):746-753. doi: 10.1007/s00246-017-1574-0.Romans R.A., Lu J.C., Balasubramanian S., Whiteside W., Yu S., Aldoss O.T., Armstrong A.K., Boe B.A., Balzer D.T., Christensen J.T. et al. Cardiac Magnetic Resonance to Predict Coronary Artery Compression in Transcatheter Pulmonary Valve Implantation Into Conduits. JACC Cardiovasc Interv. 2022;15(9):979-988. doi: 10.1016/j.jcin.2022.02.047.Romans R.A., Lu J.C., Balasubramanian S., Whiteside W., Yu S., Aldoss O.T., Armstrong A.K., Boe B.A., Balzer D.T., Christensen J.T. et al. Cardiac Magnetic Resonance to Predict Coronary Artery Compression in Transcatheter Pulmonary Valve Implantation Into Conduits. JACC Cardiovasc Interv. 2022;15(9):979-988. doi: 10.1016/j.jcin.2022.02.047.Morray B.H., McElhinney D.B., Cheatham J.P., Zahn E.M., Berman D.P., Sullivan P.M., Lock J.E., Jones T.K. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience Circ Cardiovasc Interv, 2013;6(5):535-42. doi:10.1161/CIRCINTERVENTIONS.113.000202Morray B.H., McElhinney D.B., Cheatham J.P., Zahn E.M., Berman D.P., Sullivan P.M., Lock J.E., Jones T.K. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience Circ Cardiovasc Interv, 2013;6(5):535-42. doi:10.1161/CIRCINTERVENTIONS.113.000202Patel N.D., Levi D.S., Cheatham J.P., Qureshi S.A., Shahanavaz S., Zahn E.M. Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies. J Soc Cardiovasc Angiogr Interv. 2022;1(6):100452. doi: 10.1016/j.jscai.2022.100452.Patel N.D., Levi D.S., Cheatham J.P., Qureshi S.A., Shahanavaz S., Zahn E.M. Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies. J Soc Cardiovasc Angiogr Interv. 2022;1(6):100452. doi: 10.1016/j.jscai.2022.100452.Guyon P.W.Jr., Mohammad Nijres B., Justino H., Davtyan A., Mosher B., Courelli A., Ratnayaka K., Moore J.W., El-Said H.G. Expanded Use of the One-Step Technique for Simultaneous Landing Zone Stenting and Placement of the Melody Transcatheter Pulmonary Valve. J Invasive Cardiol. 2021;33(12):E954-E959. doi: 10.25270/jic/20.00739.Guyon P.W.Jr., Mohammad Nijres B., Justino H., Davtyan A., Mosher B., Courelli A., Ratnayaka K., Moore J.W., El-Said H.G. Expanded Use of the One-Step Technique for Simultaneous Landing Zone Stenting and Placement of the Melody Transcatheter Pulmonary Valve. J Invasive Cardiol. 2021;33(12):E954-E959. doi: 10.25270/jic/20.00739.Boudjemline Y. A new one-step procedure for pulmonary valve implantation of the melody valve: simultaneous prestenting and valve implantation. Catheter Cardiovasc Interv. 2018;91(1):64–70. doi: 10.1002/ccd.27332.Boudjemline Y. A new one-step procedure for pulmonary valve implantation of the melody valve: simultaneous prestenting and valve implantation. Catheter Cardiovasc Interv. 2018;91(1):64–70. doi: 10.1002/ccd.27332.Jones T.K., McElhinney D.B., Vincent J.A., Hellenbrand W.E., Cheatham J.P., Berman D.P., Zahn E.M., Khan D.M., Rhodes J.F.Jr., Weng S., Bergersen L.J. Long-term outcomes after melody transcatheter pulmonary valve replacement in the US investigational device exemption trial. Circ Cardiovasc Interv. 2022;15(1), e010852. doi: 10.1161/CIRCINTERVENTIONS.121.010852.Jones T.K., McElhinney D.B., Vincent J.A., Hellenbrand W.E., Cheatham J.P., Berman D.P., Zahn E.M., Khan D.M., Rhodes J.F.Jr., Weng S., Bergersen L.J. Long-term outcomes after melody transcatheter pulmonary valve replacement in the US investigational device exemption trial. Circ Cardiovasc Interv. 2022;15(1), e010852. doi: 10.1161/CIRCINTERVENTIONS.121.010852.Cardoso R., Ansari M., Garcia D., Sandhu S., Brinster D., Piazza N. Prestenting for prevention of melody valve stent fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016;87(3):534–539. doi:10.1002/ccd.26235Cardoso R., Ansari M., Garcia D., Sandhu S., Brinster D., Piazza N. Prestenting for prevention of melody valve stent fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016;87(3):534–539. doi:10.1002/ccd.26235Georgiev S., Ewert P., Eicken A., Hager A., Hörer J., Cleuziou J., Meierhofer C., Tanase D. Munich Comparative Study: Prospective Long-Term Outcome of the Transcatheter Melody Valve Versus Surgical Pulmonary Bioprosthesis With Up to 12 Years of Follow-Up. Circ Cardiovasc Interv. 2020;13(7):e008963. doi: 10.1161/CIRCINTERVENTIONS.119.008963. PMID: 32600110.Georgiev S., Ewert P., Eicken A., Hager A., Hörer J., Cleuziou J., Meierhofer C., Tanase D. Munich Comparative Study: Prospective Long-Term Outcome of the Transcatheter Melody Valve Versus Surgical Pulmonary Bioprosthesis With Up to 12 Years of Follow-Up. Circ Cardiovasc Interv. 2020;13(7):e008963. doi: 10.1161/CIRCINTERVENTIONS.119.008963. PMID: 32600110.Abdelghani M., Nassif M., Blom N.A., Mourik M.S.V., Straver B., Koolbergen D.R., Kluin J., Tijssen J.G., Mulder B.J.M., Bouma B.J., de Winter R.J. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc. 2018; 7(13):e008163. doi: 10.1161/JAHA.117.008163Abdelghani M., Nassif M., Blom N.A., Mourik M.S.V., Straver B., Koolbergen D.R., Kluin J., Tijssen J.G., Mulder B.J.M., Bouma B.J., de Winter R.J. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc. 2018; 7(13):e008163. doi: 10.1161/JAHA.117.008163Van Dijck I., Budts W., Cools B., Eyskens B., Boshoff D.E., Heying R., Frerich S., Vanagt W.Y., Troost E., Gewillig M. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015;101(10):788-93. doi: 10.1136/heartjnl-2014-306761.Van Dijck I., Budts W., Cools B., Eyskens B., Boshoff D.E., Heying R., Frerich S., Vanagt W.Y., Troost E., Gewillig M. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015;101(10):788-93. doi: 10.1136/heartjnl-2014-306761.Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., Uebing A., Dähnert I., Röhle R., Schneider H., Witsenburg M., Benson L., Gitter R., Bökenkamp R., Mahadevan V., Berger F. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. doi: 10.1093/eurheartj/ehz201.Nordmeyer J., Ewert P., Gewillig M., AlJufan M., Carminati M., Kretschmar O., Uebing A., Dähnert I., Röhle R., Schneider H., Witsenburg M., Benson L., Gitter R., Bökenkamp R., Mahadevan V., Berger F. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. doi: 10.1093/eurheartj/ehz201.Sadeghi S., Wadia S., Lluri G., Tarabay J., Fernando A., Salem M., Sinha S., Levi D.S., Aboulhosn J. Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease. Catheter Cardiovasc Interv. 2019;94(4):625-635. doi: 10.1002/ccd.28474.Sadeghi S., Wadia S., Lluri G., Tarabay J., Fernando A., Salem M., Sinha S., Levi D.S., Aboulhosn J. Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease. Catheter Cardiovasc Interv. 2019;94(4):625-635. doi: 10.1002/ccd.28474.Georgiev S., Ewert P., Tanase D., Hess J., Hager A., Cleuziou J., Meierhofer C., Eicken A. A Low Residual Pressure Gradient Yields Excellent Long-Term Outcome After Percutaneous Pulmonary Valve Implantation. JACC Cardiovasc Interv. 2019;12(16):1594-1603. doi: 10.1016/j.jcin.2019.03.037.Georgiev S., Ewert P., Tanase D., Hess J., Hager A., Cleuziou J., Meierhofer C., Eicken A. A Low Residual Pressure Gradient Yields Excellent Long-Term Outcome After Percutaneous Pulmonary Valve Implantation. JACC Cardiovasc Interv. 2019;12(16):1594-1603. doi: 10.1016/j.jcin.2019.03.037.McElhinney D.B., Zhang Y., Levi D.S., Georgiev S., Biernacka E.K., Goldstein B.H., Shahanavaz S., Qureshi A.M., Cabalka A.K., Bauser-Heaton H., et al. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2022;79(1):18-32. doi: 10.1016/j.jacc.2021.10.031.McElhinney D.B., Zhang Y., Levi D.S., Georgiev S., Biernacka E.K., Goldstein B.H., Shahanavaz S., Qureshi A.M., Cabalka A.K., Bauser-Heaton H., et al. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2022;79(1):18-32. doi: 10.1016/j.jacc.2021.10.031.McElhinney D.B., Zhang Y., Aboulhosn J.A., Morray B.H., Biernacka E.K., Qureshi A.M., Torres A.J., Shahanavaz S., Goldstein B.H., Cabalka A.K., et al. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2021;78(6):575-589. doi: 10.1016/j.jacc.2021.05.044.McElhinney D.B., Zhang Y., Aboulhosn J.A., Morray B.H., Biernacka E.K., Qureshi A.M., Torres A.J., Shahanavaz S., Goldstein B.H., Cabalka A.K., et al. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement. J Am Coll Cardiol. 2021;78(6):575-589. doi: 10.1016/j.jacc.2021.05.044.Davtyan A., Guyon P.W., El-Sabrout H.R., Ponder R., Ramchandar N., Weber R., Zayed W., Ratnayaka K., Nigro J.J., Moore J.W., et al. Selective Valve Removal for Melody Valve Endocarditis: Practice Variations in a Multicenter Experience. Pediatr Cardiol. 2022;43(4):894-902. doi: 10.1007/s00246-021-02801-z.Davtyan A., Guyon P.W., El-Sabrout H.R., Ponder R., Ramchandar N., Weber R., Zayed W., Ratnayaka K., Nigro J.J., Moore J.W., et al. Selective Valve Removal for Melody Valve Endocarditis: Practice Variations in a Multicenter Experience. Pediatr Cardiol. 2022;43(4):894-902. doi: 10.1007/s00246-021-02801-z.Garay F., Webb J., Hijazi Z.M. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv. 2006;67(5):659–662. doi:10.1002/ccd.20753.Garay F., Webb J., Hijazi Z.M. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv. 2006;67(5):659–662. doi:10.1002/ccd.20753.Geva T., Gauvreau K., Powell A.J., Cecchin F., Rhodes J., Geva J., del Nido P. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010;122(11 Suppl):S201-8. doi: 10.1161/CIRCULATIONAHA.110.951178.Geva T., Gauvreau K., Powell A.J., Cecchin F., Rhodes J., Geva J., del Nido P. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010;122(11 Suppl):S201-8. doi: 10.1161/CIRCULATIONAHA.110.951178.Sinha S., Aboulhosn J., Asnes J., Bocks M., Zahn E., Goldstein B.H., Zampi J., Hellenbrand W., Salem M., Levi D. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(3):455-463. doi: 10.1002/ccd.27973.Sinha S., Aboulhosn J., Asnes J., Bocks M., Zahn E., Goldstein B.H., Zampi J., Hellenbrand W., Salem M., Levi D. Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(3):455-463. doi: 10.1002/ccd.27973.Morgan G.J., Sadeghi S., Salem M.M., Wilson N., Kay J., Rothman A., Galindo A., Martin M.H., Gray R., Ross M., Aboulhosn J.A., Levi D.S. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324-329. doi: 10.1002/ccd.27932.Morgan G.J., Sadeghi S., Salem M.M., Wilson N., Kay J., Rothman A., Galindo A., Martin M.H., Gray R., Ross M., Aboulhosn J.A., Levi D.S. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience. Catheter Cardiovasc Interv. 2019;93(2):324-329. doi: 10.1002/ccd.27932.Hussan S. Suradi, Ziyad M. Hijazi. Эндоваскулярная имплантация клапана Sapien в позицию легочной артерии. В книге: Ренгенэндоваскулярная хирургия: национальное руководство под ред. Б.Г.Алекяна. Москва: изд-во Литтерра, 2017. С. 88-97.Hussan S. Suradi, Ziyad M. Hijazi. Jendovaskuljarnaja implantacija klapana Sapien v poziciju legochnoj arterii. V knige: Rengenjendovaskuljarnaja hirurgija:nacional'noe rukovodstvo pod red. B.G.Alekjana. Moscpw: izd-vo Litterra, 2017. S. 88-97. (In Russian)Shahanavaz S., Zahn E.M., Levi D.S., Aboulhousn J.A., Hascoet S., Qureshi A.M., Porras D., Morgan G.J., Bauser Heaton H., et al. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. J Am Coll Cardiol. 2020;76(24):2847-2858. doi: 10.1016/j.jacc.2020.10.041. PMID: 33303074.Shahanavaz S., Zahn E.M., Levi D.S., Aboulhousn J.A., Hascoet S., Qureshi A.M., Porras D., Morgan G.J., Bauser Heaton H., et al. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis. J Am Coll Cardiol. 2020;76(24):2847-2858. doi: 10.1016/j.jacc.2020.10.041. PMID: 33303074.Stapleton G.E., Gowda S.T., Bansal M., Khan A., Qureshi A.M., Justino H. Sapien S3 valve deployment in the pulmonary position using the gore DrySeal sheath to protect the tricuspid valve. Catheter Cardiovasc Interv. 2020;96(6):1287–1293. doi:10.1002/ccd.29120Stapleton G.E., Gowda S.T., Bansal M., Khan A., Qureshi A.M., Justino H. Sapien S3 valve deployment in the pulmonary position using the gore DrySeal sheath to protect the tricuspid valve. Catheter Cardiovasc Interv. 2020;96(6):1287–1293. doi:10.1002/ccd.29120Kenny D., Rhodes J.F., Fleming G.A., Kar S., Zahn E.M., Vincent .J., Shirali G.S., Gorelick J., Fogel M.A., Fahey J.T., Kim D.W., Babaliaros V.C., Armstrong A.K., Hijazi Z.M. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv. 2018;11(19):1920-1929. doi: 10.1016/j.jcin.2018.06.001.Kenny D., Rhodes J.F., Fleming G.A., Kar S., Zahn E.M., Vincent .J., Shirali G.S., Gorelick J., Fogel M.A., Fahey J.T., Kim D.W., Babaliaros V.C., Armstrong A.K., Hijazi Z.M. 3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial. JACC Cardiovasc Interv. 2018;11(19):1920-1929. doi: 10.1016/j.jcin.2018.06.001.Riahi M., Blanke P., Webb J., Carere R.G. Early leaflet thrombosis complicating transcatheter implantation of a Sapien 3 valve in a native right ventricular outflow tract. Catheter Cardiovasc Interv. 2018;92(5):925–929. doi:10.1002/ ccd.27183Riahi M., Blanke P., Webb J., Carere R.G. Early leaflet thrombosis complicating transcatheter implantation of a Sapien 3 valve in a native right ventricular outflow tract. Catheter Cardiovasc Interv. 2018;92(5):925–929. doi:10.1002/ ccd.27183Shibbani K., Garg R., Zahn E.M., Mclennan D. Aspirin use and transcatheter pulmonary valve replacement, the need for consistency. Pediatr Cardiol. 2021;42(7):1640–1646. doi:10.1007/s00246-021-02652-8Shibbani K., Garg R., Zahn E.M., Mclennan D. Aspirin use and transcatheter pulmonary valve replacement, the need for consistency. Pediatr Cardiol. 2021;42(7):1640–1646. doi:10.1007/s00246-021-02652-8Meril Life Sciences Pvt. Ltd. Myval. Available at: https://www.merillife.com/medical-devices/vascular-intervention/heart-valves/TAVR/myval (accessed 04.06.2024)Meril Life Sciences Pvt. Ltd. Myval. Available at: https://www.merillife.com/medical-devices/vascular-intervention/heart-valves/TAVR/myval (accessed 04.06.2024)Rodríguez Ogando A., Ballesteros F., Martínez J.L.Z. Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve. Catheter Cardiovasc Interv. 2022;99(1):E38-E42. doi: 10.1002/ccd.29985.Rodríguez Ogando A., Ballesteros F., Martínez J.L.Z. Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve. Catheter Cardiovasc Interv. 2022;99(1):E38-E42. doi: 10.1002/ccd.29985.Sivaprakasam M.C., Arvind A., Sridhar A., Gunasekaran S. First transcatheter pulmonary valve implantation – An Indian made valve. IHJ Cardiovasc Case Rep CVCR.2020;4:13–16. doi:10.1016/j.ihjccr.2020.05.005Sivaprakasam M.C., Arvind A., Sridhar A., Gunasekaran S. First transcatheter pulmonary valve implantation – An Indian made valve. IHJ Cardiovasc Case Rep CVCR.2020;4:13–16. doi:10.1016/j.ihjccr.2020.05.005Sivaprakasam M.C., Reddy J.R.V., Gunasekaran S., Sivakumar K., Pavithran S., Rohitraj G.R., Jayranganath M., Francis E. Early multicenter experience of a new balloon expandable MyVal transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits. Ann Pediatr Cardiol. 2021;14(3):293-301. doi: 10.4103/apc.apc_242_20.Sivaprakasam M.C., Reddy J.R.V., Gunasekaran S., Sivakumar K., Pavithran S., Rohitraj G.R., Jayranganath M., Francis E. Early multicenter experience of a new balloon expandable MyVal transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits. Ann Pediatr Cardiol. 2021;14(3):293-301. doi: 10.4103/apc.apc_242_20.Houeijeh A., Sudre A., Juthier F., Godart F. Pulmonary valve replacement in a large and tortuous right ventricle outflow tract with a 32 mm Myval valve under local anaesthesia: challenges and technical considerations: a case report. Eur Heart J Case Rep. 2023;7(8):ytad322. doi: 10.1093/ehjcr/ytad322.Houeijeh A., Sudre A., Juthier F., Godart F. Pulmonary valve replacement in a large and tortuous right ventricle outflow tract with a 32 mm Myval valve under local anaesthesia: challenges and technical considerations: a case report. Eur Heart J Case Rep. 2023;7(8):ytad322. doi: 10.1093/ehjcr/ytad322.Schievano S., Coats L., Migliavacca F., Norman W., Frigiola A., Deanfield J., Bonhoeffer P., Taylor A.M. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: Implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson.2007;9(4):687–95. doi: 10.1080/10976640601187596.Schievano S., Coats L., Migliavacca F., Norman W., Frigiola A., Deanfield J., Bonhoeffer P., Taylor A.M. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: Implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson.2007;9(4):687–95. doi: 10.1080/10976640601187596.Kim G.B., Song M.K., Bae E.J., Park E.A., Lee W., Lim H.G., Kim Y.J. Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta Valve) implantation using knitted nitinol wire backbone and trileaflet α-gal-free porcine pericardial valve in the native right ventricular outflow tract. Circ Cardiovasc Interv. 2018;11(6):e006494. doi: 10.1161/CIRCINTERVENTIONS.118.006494.Kim G.B., Song M.K., Bae E.J., Park E.A., Lee W., Lim H.G., Kim Y.J. Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve (Pulsta Valve) implantation using knitted nitinol wire backbone and trileaflet α-gal-free porcine pericardial valve in the native right ventricular outflow tract. Circ Cardiovasc Interv. 2018;11(6):e006494. doi: 10.1161/CIRCINTERVENTIONS.118.006494.Garay F., Pan X., Zhang Y.J., Wang C., Springmuller D. Early experience with the Venus p valve for percutaneous pulmonary valve implantation in native outflow tract. Neth Heart J. 2017;25:76–81. doi: 10.1007/s12471-016-0932-5.Garay F., Pan X., Zhang Y.J., Wang C., Springmuller D. Early experience with the Venus p valve for percutaneous pulmonary valve implantation in native outflow tract. Neth Heart J. 2017;25:76–81. doi: 10.1007/s12471-016-0932-5.Promphan W., Prachasilchai P., Siripornpitak S., Qureshi S.A., Layangool T. Percutaneous pulmonary valve implantation with the Venus P-valve: Clinical experience and early results. Cardiol Young. 2016;26(4):698-710. doi: 10.1017/S1047951115001067.Promphan W., Prachasilchai P., Siripornpitak S., Qureshi S.A., Layangool T. Percutaneous pulmonary valve implantation with the Venus P-valve: Clinical experience and early results. Cardiol Young. 2016;26(4):698-710. doi: 10.1017/S1047951115001067.

The authors declare that there are no conflicts of interest present.